Corregene Biotechnology
Organization
Trials
CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
Phase 1, Status unknown, 12 people, Nov 16, 2021
Sources: clinicaltrials.gov
Organization
CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
Phase 1, Status unknown, 12 people, Nov 16, 2021
Sources: clinicaltrials.gov